Trials, Tales and Trails - Episode 3 - Catherine Canales: Mind the gap! Acting towards equity and the (un)funny thing about sexism in the workplace - Trials, Tales and Trails

Episode 3 - Catherine Canales: Mind the gap! Acting towards equity and the (un)funny thing about sexism in the workplace - Trials, Tales and Trails

12/13/23 • 49 min

Lifetime entrepreneur Catherine Canales chats to a very chilly Andy and warm and cosy Chris about her book on why sexism in the workplace is no joke, and gives practical tips on how to speak up against inappropriate behaviour, in episode 3 of Trials, Tales and Trails. She tells of her work coaching women in business on negotiation via NoGap and her mission to help cut the 130+ year odyssey to salary equity. Catherine speaks of her hope for the future through a steadfast next generation, and how a childhood business plan gone awry helped build her entrepreneurial spirit.

Previous Episode

Episode 2 - Ray Collia: The Why, 'Kiai' and the trouble with AI - Trials, Tales and Trails

Raconteur extraordinaire Ray Collia of Word Ferret joins Chris Wells and Andy Thurstan 'in the campervan' for episode two of Trials, Tales and Trails - the still-new podcast for the pharmaceutical clinical research and drug development industry. 'Kiai' is Japanese for fighting spirit and the theme runs right through this episode: Ray tells us about his personal promise to give something back to the healthcare world, and how an encounter at an elite karate camp has inspired him when times get tough. We chat about his lifelong association with technology - from Space Invaders to the Mario Brothers and how he attended his first tech conference before he even hit high school - as well as his fears (and hopes) for Artificial Intelligence.

Next Episode

Episode 4 - Dr Sébastien Coppe: One way or another? Digging into data for better patient choices - Trials, Tales and Trails

TTT hits the road, and for the first time we haven't recorded in the campervan! This episode explores how big data can be used to gauge net treatment benefit (NTB) to allow patients, clinicians and researchers to make better informed choices during clinical trials. Definitely one for the lovers of data and statistics, mathematician and researcher Dr Sébastien Coppe - CEO of One2Treat - talks to Andy and Chris about leveraging data to create single endpoints and reduce sample sizes, cutting costs and promoting choice.